×
About 5,170 results

Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community
https://www.nccn.org/covid-19/
NCCN

NCCN recognizes the rapidly changing medical information relating to COVID-19 in the oncology ecosystem, but understands that a forum for sharing best practices and specific institutional responses may be helpful to others. Therefore, we are expeditiously providing documents and recommendations developed by NCCN Member Institutions or Guideline Panels as resources for oncology care providers. ...

Muscle-invasive and Metastatic Bladder Cancer
https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/

The European Association of Urology (EAU) Guidelines Panel for Muscle-invasive and Metastatic Bladder Cancer (MIBC) have prepared these guidelines to help urologists assess the evidence-based management of MIBC and to incorporate guideline recommendations into their clinical practice.

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer
https://www.jstage.jst.go.jp/article/endocrj/advpub/0/advpub_EJ20-0025/_pdf/-char/en
Endocrine Journal;

 The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the therapeutic management of thyroid cancers. The objective of the guidelines is to improve health-related outcomes in patients with thyroid tumors by en...

COVID-19 Guidelines for Triage of Breast Cancer Patients
https://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancer

Triage of Breast Cancer Patients, American College of Surgeons

Bladder Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/bladder/hp/bladder-treatment-pdq?cid=eb_govdel

Bladder cancer is the sixth most common cancer in the United States after lung cancer, prostate cancer, breast cancer, colon cancer, and lymphoma. It is the third most common cancer in men and the eleventh most common cancer in women. Of the roughly 70,000 new cases annually, about 53,000 are in men and about 18,000 are in women. Of the roughly 15,000 annual deaths, more than 10,000 are in men ...

ASCO Coronavirus Resources
https://www.asco.org/asco-coronavirus-information

As the coronavirus (COVID-19) continues to spread, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that individuals with cancer receive high-quality care. ASCO has compiled a wide range of resources to support clinicians, the cancer care delivery team, and patients with cancer. This is a rapidly evolving s...

AUA Guidelines 2020: Microhematuria
https://www.urotoday.com/conference-highlights/aua-2020/aua-2020-bladder-health/122536-aua-guidelines-2020-microhematuria.html?pk_campaign=Barocas_SocialAUALive_122536

(UroToday.com) The guidelines for microhematuria were formulated by a multidisciplinary panel with representations from the American Urological Association (AUA), Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), and American College of Obstetricians and Gynecologists (ACOG), as well as Bladder Cancer Advocacy Network (BCAN) patient advocate. The guidelines w...

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.5.2020
https://www2.tri-kobe.org/nccn/guideline/breast/english/breast.pdf

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
https://www.annalsofoncology.org/article/S0923-7534(19)34113-4/fulltext

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
https://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21319

Breast Cancer Risk Assessment and Screening in Average-Risk Women
https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/07/breast-cancer-risk-assessment-and-screening-in-average-risk-women

Final Recommendation Statement Breast Cancer: Screening
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
US Preventive Services Task Force

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831582/

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
https://ascopubs.org/doi/10.1200/JCO.2016.67.1487

American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/canjclin.57.2.75

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://www.annalsofoncology.org/article/S0923-7534(19)60966-X/fulltext

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
https://www.annalsofoncology.org/article/S0923-7534(19)31645-X/fulltext

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
https://watermark.silverchair.com/arpa_2018-0902-sa.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAqYwggKiBgkqhkiG9w0BBwagggKTMIICjwIBADCCAogGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMwDEwsOmbjOqRnJ6aAgEQgIICWS3W9tuwe5KamZySj3dHjEZ1KbaS8MdI2N2ghtxTL9k9a0ZJ_leAlzcTwf4ZMJ8WsAY2Qo8v6XH-wwAvib8mfGLP7QLkKU6uMhpolnlHNBiWzDPehHA7eFRrrOMdCOxGyPnPHeg24hIU-tU57qO6sQap4az3fT8MtNT3fgZUV2ruNEPsbCR8Oj_bVwnpd-6M_mMPo9fmzDH6nhyCzg1x7Qls49Rx2nQcNk9qOn8qZnrSMKclnlIAw8fd_9PbycmKpkSPCjtvcZUacP57C1aYKQrUzwb7mNM8xFRozFw5tl_4lvpgH2Gk7rGj5WxsEu6FQdTt045rUnINhQeIBBbHqEfSoaq5vNzDh_kUb5h9UuyG14BF1Ebxvm1xdo0HGTSM9i_9dupCb5Rb-Yz8dU2UILJkSlsMh89Gm5LnFeVCOhWWrC94hUrBO1WJUeT-HBDF715moIuyG1UJWW1URbzWrRtf3aBzMfkjwyTZHR9kbCjDwS4tHwY5WFPR7fJtyy77ToEKqIk_WvnG5KSKAMWPvtiMd5FLalKMmQi2LVGkm0NWMbpiOwH2wyc1W-jb6kuASA2S6uZw0CwXHj0GmXGx3jlWekgm9ENyTB_GIxMMdpT5vs1EUBaGSIedmzNa0QiduBE6vWfPEKiAbPUKKMVa7NaFfrAD5CcSxh38EJuELVg3JrK9SO9_XOdIjPP3KiNA9oGoaKNToA4xJKfTaStSLNu8Wv4k96rw3pM5qqyEenxu2aGje8o2ThKyCjOpGCzGSpciR-CSYm7Ss9HCzTdZ8Ta6pFH860xWHRg

ESMO Guideline for Cancer Patient Management During the COVID-19 Pandemic
https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic?hit=ehp

Sep 17th, 2020 - These recommendations should be used as guidance for prioritising the various aspects of cancer care in order to mitigate the negative effects of the COVID-19 pandemic on the management of cancer patients. The situation is evolving, and pragmatic actions may be required to deal with the challenges of treating patients, while ensuring their rights, safety and wellbeing.

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
https://ascopubs.org/doi/10.1200/JCO.20.00299